PHOENIXDX® 2019-NCOV

Artikel-Nr.: M3139.0050
Shipping: shipped on wet ice, store at -20°C Lieferzeit: 3 - 8 Werktage
Für genaue Informationen zum Liefertermin wenden Sie sich bitte an Genaxxon.
Preise zzgl. gesetzlicher MwSt. zzgl. Versandkosten
Infos Lieferbedingungen & Versandkosten >>
PHOENIXDX® 2019-NCOV is a real-time RT-PCR-based detection system for the 2019 Wuhan coronavirus (2019-nCoV). The kit comes as 20-time RT-PCR master mix.
PHOENIXDX® 2019-NCOV is a real-time RT-PCR-based detection system for the 2019 Wuhan coronavirus (2019-nCoV). 2019-nCoV is considered a novel human coronavirus that is genetically distinct from the common human coronaviruses (229E, NL63, OC43, HKU1), which cause seasonal acute respiratory illness. It is also genetically distinct from the two newer human coronaviruses, MERS-CoV and SARS-CoV.
PHOENIXDX® 2019-NCOV detects the presence of two different and highly specific gene sequences of 2019-nCoV: E gene and RdRP gene.
Additionally, a non-infectious positive control is included. The positive control is used to confirm functionality of the assays and overall PCR performance, the negative human extraction control assay is included to evaluate the quality of the RNA isolation independently from the 2019-nCoV assays.
All primers and probes are tested to be not contaminated with template RNA or DNA (positive control RNA).
Technische Daten:
Specifications:
20-time RT-qPCR master mix with
1 x 150µL PhoenixDx® Enzyme Mix
1 x 750µL PhoenixDx® E gene Mix
1 x 750µL PhoenixDx® RdRP Mix
1 x 750µL PhoenixDx® HEC Mix
1 x 200µL 2019-nCoV Target Positive Control (TPC)
Enzyme mix for 50 x 20µL qPCR reactions
Applikation:
SARS-CoV-2 RT-qPCR realtime PCRQuelle
syntheticSicherheits Hinweise / Safety
Klassifizierungen / Classification
eclass-Nr: 34-16-04-90Dokumente - Protokolle - Downloads
Hier finden Sie Informationen und weiterführende Literatur zu PHOENIXDX® 2019-NCOV. Für weitere Dokumente (Zertifikate mit weiteren Lotnummern, Sicherheitsdatenblätter in anderer Sprache, weitere Produktinformationen) wenden Sie sich bitte an Genaxxon biosience unter: info@genaxxon.com oder Tel.: +49 731 3608 123.